Observational studyBMJ open2025
Maternal, fetal and neonatal adverse outcomes associated with gestational diabetes: a prospective cohort study at King Faisal Hospital, Kigali.
Observational study in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe study aimed to evaluate the cumulative incidence of gestational diabetes (GD) among pregnant women receiving antenatal care at the King Faisal Hospital (KFH) in Kigali, Rwanda, using the criteria established by the International Association of Diabetes and Pregnancy Study Groups and endorsed by the WHO in 2013.
designProspective cohort study.
settingKFH-Kigali, Rwanda.
participantsA total of 284 pregnant women were enrolled between May 2023 and April 2024.
resultsThe cumulative incidence rate of GD was 19.5% (95% CI 15% to 24.6%). Most participants (78%) were from Kigali City. Most participants belong to high-income households (96.5%) and were employed (85%). Risk factors associated with the development of GD included increased body mass index (adjusted relative risk (aRR) 3.2; 95% CI 2.02 to 5.3), a history of macrosomia (aRR 4.9; 95% CI 1.6 to 12) and family history of type 2 diabetes (aRR 4.6; 95% CI 1.3 to 14). Women diagnosed with GD had a significantly higher risk of adverse outcomes, including pre-eclampsia and gestational hypertension (aRR 6.7; 95% CI 1.7 to 26) polyhydramnios (aRR 6.4; 95% CI 1.94 to 8.9), postpartum haemorrhage (aRR 3; 95% CI 2.7 to 3.9) and caesarean delivery (aRR 4.9; 95% CI 1.6 to 9.1). Neonatal complications were also common in infants born to mothers with GD, including neonatal hypoglycaemia (aRR 2.2; 95% CI 1.2 to 4.5), neonatal intensive care unit admission (aRR 1.7; 95% CI 1 to 4.6) and macrosomia (aRR 2.3; 95% CI 1.01 to 3.5).
conclusionsThis study provides important data on the cumulative incidence of GD at the KFH in Rwanda and highlights the key maternal and neonatal factors and adverse outcomes associated with the condition. Given the growing global burden of obesity and diabetes, further research and public health education are essential for mitigating the double burden of GD on maternal and neonatal health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.